Ad
related to: fun facts about bulimia nervosa and anxiety definition treatment options
Search results
Results From The WOW.Com Content Network
He specified treatment options and indicated the seriousness of the disease, which can be accompanied by depression and suicide. [107] In 1980, bulimia nervosa first appeared in the DSM-III. [107] After its appearance in the DSM-III, there was a sudden rise in the documented incidents of bulimia nervosa. [106]
The findings suggest that cognitive behavior therapy, when applied to patients with bulimia nervosa, operates through mechanisms specific to this treatment and is more effective than both interpersonal psychotherapy and a simplified behavioral version of cognitive behavior therapy.
This is an accepted version of this page This is the latest accepted revision, reviewed on 13 February 2025. Mental illness characterized by abnormal eating habits that adversely affect health Medical condition Eating disorder Specialty Psychiatry, clinical psychology Symptoms Abnormal eating habits that negatively affect physical or mental health Complications Anxiety disorders, depression ...
Emotional eating, also known as stress eating and emotional overeating, [1] is defined as the "propensity to eat in response to positive and negative emotions". [2] While the term commonly refers to eating as a means of coping with negative emotions, it sometimes includes eating for positive emotions, such as overeating when celebrating an event or to enhance an already good mood.
NES has a substantial association with medical diagnoses such as obesity, sleep apnea, hypercholesterolemia, polycystic ovarian syndrome, and diabetes mellitus type II , and psychiatric diagnoses such as binge eating disorder, anorexia nervosa, bulimia nervosa, generalized anxiety disorder, major depressive disorder, and substance use disorders.
Lisdexamfetamine is an FDA-approved appetite suppressant drug that is indicated (i.e., used clinically) for the treatment of binge eating disorder. [19] The antidepressant fluoxetine is a medication that is approved by the Food and Drug Administration for the treatment of an eating disorder, specifically bulimia nervosa.
The group that reported the most 'menu anxiety' was Gen Z, with 34% of 18 to 24 year olds admitting they ask other people at the table to speak to waiters on their behalf, because they are too ...
Atypical bulimia nervosa In this sub-threshold version of BN, individuals meet all criteria for BN, with the exception of the frequency criterion: binge eating and inappropriate compensatory behaviors occur, on average, less than once a week and/or for fewer than 3 months.